PWG
CVS icon

Portside Wealth Group’s CVS Health CVS Stock Holding History

Portside Wealth Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.28M Sell
31,747
-2,822
-8% -$252K 0.38% 63
2026
Q1 		$2.48M Buy
34,569
+2,594
+8% +$200K 0.34% 69
2025
Q4 		$2.54M Buy
31,975
+923
+3% +$72.8K 0.34% 66
2025
Q3 		$2.34M Buy
31,052
+1,115
+4% +$76.4K 0.32% 70
2025
Q2 		$2.07M Sell
29,937
-898
-3% -$58.9K 0.31% 75
2025
Q1 		$2.09M Buy
30,835
+3,956
+15% +$237K 0.34% 74
2024
Q4 		$1.21M Sell
26,879
-1,387
-5% -$77.8K 0.2% 114
2024
Q3 		$1.78M Buy
28,266
+2,309
+9% +$135K 0.3% 82
2024
Q2 		$1.53M Buy
25,957
+13,768
+113% +$861K 0.29% 86
2024
Q1 		$972K Sell
12,189
-134
-1% -$10.2K 0.18% 131
2023
Q4 		$973K Sell
12,323
-3,178
-21% -$226K 0.18% 128
2023
Q3 		$1.08M Buy
15,501
+943
+6% +$66.8K 0.2% 113
2023
Q2 		$1.01M Buy
+14,558
New +$1.04M 0.19% 125

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Portside Wealth Group's CVS Position: Q2 2026 in Review

Portside Wealth Group reduced its CVS Health (CVS) stake by 8.2% in Q2 2026, selling an estimated $252K and leaving 31,747 shares worth $3.28M. The position accounts for 0.38% of the portfolio, ranked #63.

Portside Wealth Group first reported a position in CVS in Q2 2023 and has held it in 13 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Portside Wealth Group held 31,747 shares of CVS Health worth $3.28M as of Q2 2026.
  • Portside Wealth Group sold 2,822 CVS Health shares in Q2 2026, an estimated $252K.
  • CVS Health made up 0.38% of Portside Wealth Group's portfolio in Q2 2026, its #63 holding.
  • Portside Wealth Group first reported a position in CVS Health in Q2 2023 and has held it in 13 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Portside Wealth Group's 13F filing for Q2 2026, filed 14 Jul 2026.